Mentioned On
Episode Mentions
Squawk Pod · Apr 24, 2026
David Sacks, Anthropic, & the White House, Regeneron’s Deafness Cure 4/24/26
“FDA approved Otarmony gene therapy for genetic deafness; offering treatment free to U.S. patients; negotiated drug pricing deal with Trump administration”
AI Chip Demand and Semiconductor SupplyGovernment AI Procurement and Use RestrictionsAI Model Bias and Political Alignment
View AnalysisPharma and BioTech Daily · Apr 24, 2026
Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily
“Achieved FDA approval for Otarmini, a gene therapy for hearing loss, using the National Priority Voucher Program”
Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes
View Analysis